Intraoperative near-infrared autofluorescence imaging for hypocalcemia risk reduction after total thyroidectomy: Evidence from a meta-analysis.
Yu-Jing WengJiang JiangLei MinQing AiDe-Biao ChenWei-Chun ChenZhi-Heng HuangPublished in: Head & neck (2021)
This meta-analysis evaluates whether near-infrared autofluorescence (NIRAF) imaging reduces the risk of hypocalcemia after total thyroidectomy. A systematic literature search in PubMed, EMBASE, Web of Science, and Cochrane Library for studies from June 2011 to January 2021 comparing total thyroidectomy with NIRAF and conventional surgery (naked eye). Six eligible studies involving 2180 patients were included. The prevalence of transient hypocalcemia was 8.11% (40/493) and 25.19% (425/1687) in the NIRAF and naked eye groups (p < 0.0001), respectively. The prevalence of permanent hypocalcemia was 0% (0/493) and 2.19% (37/1687) in the NIRAF and naked eye groups (p = 0.05), respectively. NIRAF reduces the risk of transient hypocalcemia and may possibly lower the rate of permanent hypocalcemia. Nonetheless, further studies are needed to verify our results and evaluate the cost-effectiveness of NIRAF in real-world clinical practice.
Keyphrases
- case control
- systematic review
- high resolution
- clinical practice
- risk factors
- end stage renal disease
- newly diagnosed
- ejection fraction
- public health
- chronic kidney disease
- papillary thyroid
- minimally invasive
- cerebral ischemia
- patients undergoing
- peritoneal dialysis
- meta analyses
- patient reported outcomes
- mass spectrometry
- fluorescence imaging
- atrial fibrillation
- randomized controlled trial
- brain injury
- acute coronary syndrome
- subarachnoid hemorrhage